Literature DB >> 2809347

Implementation of chemoprophylaxis of leprosy in the Southern Marquesas with a single dose of 25 mg per kg rifampin.

J L Cartel1, S Chanteau, J P Boutin, R Taylor, R Plichart, J Roux, P Celerier, J H Grosset.   

Abstract

Between 1967 and 1987 in the Southern Marquesas, a remote archipelago in French Polynesia, the detection rate of leprosy was 48.9 per 100,000 when it was 8.6 per 100,000 for French Polynesia as a whole. In 1988, a program of chemoprophylaxis of leprosy with a single dose of 25 mg/kg rifampin was implemented, and 2751 persons (98.7% of the population) were treated in the Southern Marquesas. In addition, 678 South Marquesans and 2466 members of their families living in the Northern Marquesas and in the Society Archipelago, received the same chemoprophylaxis. Among 2676 persons studied in the Southern Marquesas (97.4% of the treated population), 130 had elevated IgM anti-phenolic glycolipid-I antibodies by ELISA without any evidence of leprosy. The onset of a skin lesion of borderline leprosy in a boy 3 months after chemoprophylaxis raises the question of the nature of such a skin lesion and, indirectly, of the effectiveness of the chemoprophylaxis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2809347

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN: 0148-916X


  6 in total

Review 1.  The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.

Authors:  Anne Schoenmakers; Liesbeth Mieras; Teky Budiawan; Wim H van Brakel
Journal:  Res Rep Trop Med       Date:  2020-10-15

2.  Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.

Authors:  F Johannes Moet; David Pahan; Linda Oskam; Jan H Richardus
Journal:  BMJ       Date:  2008-03-10

3.  Leprosy Post-Exposure Prophylaxis (LPEP) programme: study protocol for evaluating the feasibility and impact on case detection rates of contact tracing and single dose rifampicin.

Authors:  Tanja Barth-Jaeggi; Peter Steinmann; Liesbeth Mieras; Wim van Brakel; Jan Hendrik Richardus; Anuj Tiwari; Martin Bratschi; Arielle Cavaliero; Bart Vander Plaetse; Fareed Mirza; Ann Aerts
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

4.  Protocol, rationale and design of PEOPLE (Post ExpOsure Prophylaxis for LEprosy in the Comoros and Madagascar): a cluster randomized trial on effectiveness of different modalities of implementation of post-exposure prophylaxis of leprosy contacts.

Authors:  Nimer Ortuno-Gutierrez; Assoumani Younoussa; Andriamira Randrianantoandro; Sofie Braet; Bertrand Cauchoix; Stéphanie Ramboarina; Abdallah Baco; Aboubacar Mzembaba; Zahara Salim; Mohamed Amidy; Saverio Grillone; Jan Hendrik Richardus; Bouke C de Jong; Epco Hasker
Journal:  BMC Infect Dis       Date:  2019-12-05       Impact factor: 3.090

5.  Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.

Authors:  Shannon M Lenz; Jaymes H Collins; Nashone A Ray; Deanna A Hagge; Ramanuj Lahiri; Linda B Adams
Journal:  PLoS Negl Trop Dis       Date:  2020-09-16

6.  Population-wide administration of single dose rifampicin for leprosy prevention in isolated communities: a three year follow-up feasibility study in Indonesia.

Authors:  Anuj Tiwari; Steaven Dandel; Rita Djupuri; Liesbeth Mieras; Jan Hendrik Richardus
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.